Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations.

Autoria(s): Sidi, Samuel; Hagen, Andreas T.; Kennedy, Richard; Imamura, Shintaro; Kishi, Shuji; Kanki, John; D'Andrea, Alan; Look, A. Thomas
Data(s)

16/11/2006
Identificador

http://pure.qub.ac.uk/portal/en/publications/modifier-genetics-in-zebrafish-identify-chk1-and-an-associated-survival-pathway-as-targets-for-pharmacotherapy-of-mdsaml-with-p53-mutations(076a3b02-5354-49a8-8510-ab51764da4f7).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Sidi , S , Hagen , A T , Kennedy , R , Imamura , S , Kishi , S , Kanki , J , D'Andrea , A & Look , A T 2006 , ' Modifier genetics in zebrafish identify Chk1 and an associated survival pathway as targets for pharmacotherapy of MDS/AML with P53 mutations. ' Blood , vol 108 , no. 11 , pp. 416A-416A .
Tipo

article
Acesso ao item digital